Autres langues CombiGene AB

Actions

LARK

SE0016101935

Recherche biotechnologique et médicale

Temps Différé Nasdaq Stockholm 10:31:03 14/09/2026			Varia. 5j.	Varia. 1 janv.
2,320 ^SEK	0,00%		+0,87%	+2,65%

20/08	Lärkberget AB (publ) publie ses résultats pour le semestre clos le 30 juin 2026	CI
21/04	Larkberget va procéder à une augmentation de capital avec maintien du droit préférentiel de souscription de 14,9 millions SEK	RE

Autres langues

20/08	Lärkberget AB Reports Earnings Results for the Half Year Ended June 30, 2026
21/04	Larkberget to carry out rights issue of units totaling SEK 14.9 mln
17/04	Larkberget net asset value per share at SEK 3.04
12/02	Lärkberget reports H2 revenue loss of SEK 252,000
12/02	Lärkberget AB Reports Earnings Results for the Full Year Ended December 31, 2025
12/02	Lärkberget AB announces Annual dividend, payable on May 15, 2026
03/02	Larkberget appoints Luca Di Stefano as CEO
21/01	Lårkberget net asset value per share as of Jan 15, 2025 is SEK 3.08
22/10/25	Nasdaq Stockholm removes Larkberget's observation status
06/10/25	Larkberget invests SEK 50 mln in Naxs AB
22/08/25	Lärkberget AB Reports Earnings Results for the Half Year Ended June 30, 2025
22/08/25	Larkberget H1 net sales amounted to 252 Tsek
17/06/25	Combigene Appoints Robert Klatzkow As Chairman
12/06/25	Combigene Says Company Name Changed To Lärkberget
11/06/25	Combigene Informs About Proposed Strategic Changes In Co's Operations
23/05/25	CombiGene AB announces Annual dividend, payable on June 19, 2025
20/05/25	Combigene Says Nasdaq Decides No New Listing Process Required For Combigene
15/05/25	Combigene To Change Name To Lärkberget
14/02/25	CombiGene : Year end report January December 2024 CombiGene AB (Publ)
14/02/25	Combigene Q4 Result After Financial Items Down To SEK -14,2 Mln
14/02/25	Year-end report January-December 2024 CombiGene AB (Publ)
14/02/25	Lärkberget AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024
28/01/25	Discontinuation of research activities
28/01/25	CombiGene AB Discontinuation of Research Activities
09/01/25	Sweden's CombiGene Cuts All Jobs in Major Restructuring Move